Disability Improvements with Ublituximab in Relapsing Multiple Sclerosis (RMS): Expanded Disability Status Scale (EDSS), 9-Hole Peg Test (9-HPT), and Timed 25-Foot Walk (T25FW) Evaluations from the Phase 3 ULTIMATE I and II Studies

Download

Drug Category : Array

Conference Category : Array

Lead Author : Cree B, et al.

Published Date : 03/04/2022

Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2022/04/Cree_Disability-Impr_AAN2022.pdf

Download Text : Download

Popup Confirmation? :

site-sidebar-layout : default

ast-site-content-layout : default

site-content-style : default

site-sidebar-style : default

theme-transparent-header-meta : default

stick-header-meta : default

astra-migrate-meta-layouts : set